Malarone(TM) (atovaquone and proguanil hydrochloride): A review of its clinical development for treatment of malaria

American Journal of Tropical Medicine and Hygiene

Volumn 60, Issue 4, 1999, Pages 533-541

  Looareesuwan, Sornchai ^a   Chulay, Jeffrey D ^b   Canfield, Craig J ^c   Hutchinson, David B A ^d   De Alencar, F ^e   Anabwani, G ^e   Attanath, P ^e   Bienzle, U ^e   Bouchaud, O ^e   Bustos, D ^e   Campos, P ^e   Cerutti, C ^e   Charoenlarp, P ^e   Chiodini, P ^e   Chongsuphajaisiddihi, T ^e   Clendenes, M ^e   Conlon, C ^e   Coulaud, J P ^e   Danis, M ^e   Ekue, J M K ^e   Gay, F ^e   Gentilini, M ^e   Graninger, W ^e   Hall, A P ^e   Kawesha, C ^e   Kremsner, P ^e   Kyle, D ^e   Laothavarn, J ^e   LeBras, J ^e   Llanos Cuentos, A ^e   Milhous, W ^e   Monlun, E ^e   Muanza, K ^e   Mukunyandela, M ^e   Mulenga, M ^e   Pang, L ^e   Peto, T E A ^e   Philipps, J ^e   Radloff, P ^e   Sabchareon, A ^e   Signhasivaron, V ^e   Viravan, C ^e   Warrell, D ^e   Webster, H K ^e   Wilairatana, P ^e   more..

^a MAHIDOL UNIVERSITY   (Thailand)

^b GLAXOSMITHKLINE   (United States)

^c Pharmaceutical Systems Inc   (United States)

^d Betsoms Farmhouse   (United Kingdom)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ATOVAQUONE; ATOVAQUONE PLUS PROGUANIL; CHLOROQUINE; DOXYCYCLINE; FANSIDAR; HALOFANTRINE; MEFLOQUINE; PROGUANIL; PYRIMETHAMINE; QUININE; TETRACYCLINE; ANTIMALARIAL AGENT; NAPHTHOQUINONE;

ABDOMINAL PAIN; ANOREXIA; ARTICLE; BRAZIL; CLINICAL TRIAL; COUGHING; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; FRANCE; GABON; HUMAN; KENYA; MALARIA; NAUSEA; PARASITEMIA; PERU; PHILIPPINES; PLASMODIUM FALCIPARUM; THAILAND; VOMITING; ZAMBIA; ADULT; AGED; CHILD; CONTROLLED CLINICAL TRIAL; DRUG COMBINATION; MALARIA FALCIPARUM; RANDOMIZED CONTROLLED TRIAL; REVIEW;

ADULT; AGED; ANTIMALARIALS; ATOVAQUONE; CHILD; CHLOROGUANIDE; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; HUMANS; MALARIA, FALCIPARUM; NAPHTHOQUINONES; RANDOMIZED CONTROLLED TRIALS;

EID: 0033110869     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1999.60.533     Document Type: Article

References (22)

1. Chiodini PL, Conlon CP, Hutchinson DB, Farquhar JA, Hall AP, Peto TE, Birley H, Warrell DA, 1995. Evaluation of atovaquone in the treatment of patients with uncomplicated Plasmodium falciparum malaria. J Antimicrob Chemother 36: 1073-1078.
2. Looareesuwan S, Viravan C, Webster HK, Kyle DE, Hutchinson DB, Canfield CJ, 1996. Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. Am J Trop Med Hyg 54: 62-66.
3. Radloff PD, Philipps J, Nkeyi M, Hutchinson D, Kremsner PG, 1996. Atovaquone and proguanil for Plasmodium falciparum malaria. Lancet 347: 1511-1514.
4. Radloff PD, Philipps J, Hutchinson D, Kremsner PG, 1996. Atovaquone plus proguanil is an effective treatment for Plasmodium ovale and P. malariae malaria. Trans R Soc Trop Med 90: 682.
5. de Alencar FE, Cerutti C Jr, Durlacher RR, Boulos M, Alves FP, Milhous W, Pang LW, 1997. Atovaquone and proguanil for the treatment of malaria in Brazil. J Infect Dis 175: 1544-1547.
6. Looareesuwan S, Wilairatana P, Chalermarut K, Rattanapong Y, Canfield CJ, Hutchinson DBA, 1999. Efficacy and safety of atovaquone/proguanil compared with mefloquine for treatment of acute Plasmodium falciparum malaria in Thailand. Am J Trop Med Hyg 60: 526-532.
7. Sabchareon A, Attanath P, Phanuaksook P, Chanthavanich P, Poonpanich Y, Mookmanee D, Chongsuphajaisiddhi T, Sadler B, Hussein Z, Canfield C, Hutchinson D, 1998. Efficacy and pharmacokinetics of atovaquone and proguanil in children with multidrug-resistant Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg 92: 201-206.
8. Mulenga M, Canfield CJ, Hutchinson DBA, 1999. Atovaquone/ proguanil versus pyrimethamine/sulfadoxine for treatment of acute falciparum malaria in Zambia. Clin Ther: (in press).
9. Anabwani G, Canfield CJ, Hutchinson DBA, 1999. Combination atovaquone and proguanil hydrochloride versus halofantrine for treatment of acute Plasmodium falciparum malaria in children. Pediatr Infect Dis J: (in press).
10. Bustos CG, Canfield CJ, Hutchinson DBA, 1999. Atovaquone/ proguanil compared with chloroquine and chloroquine/sulfadoxine/pyrimethamine for treatment of acute Plasmodium falciparum malaria in The Philippines. J Infect Dis: (in press).
11. World Health Organization, 1973. Chemotherapy of malaria and resistance to antimalarials. World Health Organ Tech Rep Ser 529: 30-32.
12. Chulay JD, Schneider I, Cosgriff TM, Hoffman SL, Ballou WR, Quakyi IA, Carter R, Trosper JH, Hockmeyer WT, 1986. Malaria transmitted to humans by mosquitoes infected from cultured Plasmodium falciparum. Am J Trop Med Hyg 35: 66-68.
13. Hudson AT, Dickins M, Ginger CD, Gutteridge WE, Holdich T, Hutchinson DB, Pudney M, Randall AW, Latter VS, 1991. 566C80: a potent broad spectrum anti-infective agent with activity against malaria and opportunistic infections in AIDS patients. Drugs Exp Clin Res 17: 427-435.
14. Fry M, Pudney M, 1992. Site of action of the antimalarial hydroxynaphthoquinone, 2-[trans-4-(4′-chlorophenyl) cyclohexyl]-3-hydroxy-1,4-naphthoquinone (566C80). Biochem Pharmacol 43: 1545-1553.
15. Canfield CJ, Pudney M, Gutteridge WE, 1995. Interactions of atovaquone with other antimalarial drugs against Plasmodium falciparum in vitro. Exp Parasitol 80: 373-381.
16. Blanchard TJ, Mabey DC, Hunt-Cooke A, Edwards G, Hutchinson DB, Benjamin S, Chiodini PL, 1994. Multiresistant falciparum malaria cured using atovaquone and proguanil. Trans R Soc Trop Med 88: 693.
17. Hughes WT, 1995. The role of atovaquone tablets in treating Pneumocystis carinii pneumonia. J Acquir Immune Defic Syndr Hum Retrovirol 8: 247-252.
18. Erikkson B, Bjorkman A, Keiau M, 1991. How safe is proguanil? A post-marketing investigation of side effects. Scand J Infect Dis 23: 489-493.
19. Tracy J, Webster L, 1996. Drugs used in the chemotherapy of malaria. Hardman J, Gilman A, Limbird L, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. Ninth edition. New York: McGraw-Hill Companies, 965-985.
20. Pudney M, Gutteridge W, Zeman A, Dickins M, Woolley JL, 1999. Atovaquone and proguanil hydrochloride: a review of nonclinical studies. J Travel Med: (in press).
21. Looareesuwan S, White NJ, Chittamas S, Bunnag D, Harinasuta T, 1987. High rate of Plasmodium vivax relapse following treatment of falciparum malaria in Thailand. Lancet 2: 1052-1055.
22. Gassis S, Rathod PK, 1996. Frequency of drug resistance in Plasmodium falciparum: a nonsynergistic combination of 5-fluoroorotate and atovaquone suppresses in vitro resistance. Antimicrob Agents Chemother 40: 914-919.